Explore the categories so you can find more about your search.

Categorie > Liver Disease / Hepatitis

Effects Of Portal Hypertension In Rats Reversed By Combination Therapy, Promising Implications For Human Patients

Categorie : Liver Disease / Hepatitis
A combined treatment with rapamycin and Gleevec might reverse the effects of portal hypertension in patients with chronic liver disease, according to the results of a new study on rats. The study is in the October issue of Hepatology, a journal published by John Wiley & Sons on behalf of the Ame ...

read more A combined treatment with rapamycin and Gleevec might reverse the effects of portal hypertension in patients with chronic liver disease, according to the results of a new study on rats. The study is in the October issue of Hepatology, a journal published by John Wiley & Sons on behalf of the Ame read more Sun Oct 2007 Sun Oct 2007

Outcomes For Patients With Hepatitis C Improved By Weight-Based Dosing Of Ribavirin

Categorie : Liver Disease / Hepatitis
Patients with hepatitis C treated with combination therapy of pegylated interferon and ribavirin had better outcomes when taking a weight-based dosage of ribavirin compared to a flat dosage. This treatment technique also improved the response rates of African American patients, whose outcomes ha ...

read more Patients with hepatitis C treated with combination therapy of pegylated interferon and ribavirin had better outcomes when taking a weight-based dosage of ribavirin compared to a flat dosage. This treatment technique also improved the response rates of African American patients, whose outcomes ha read more Sun Oct 2007 Sun Oct 2007

News From The Annals Of Internal Medicine

Categorie : Liver Disease / Hepatitis
Trial of Two Drugs Finds One Better at Suppressing Hepatitis B VirusA 52-week, randomized trial involving 135 people with chronic hepatitis B virus (HBV) compared an older drug adefovir dipivoxil and a newer drug, telbivudine. Researchers found that telbivudine was better at suppressing blood vi ...

read more Trial of Two Drugs Finds One Better at Suppressing Hepatitis B VirusA 52-week, randomized trial involving 135 people with chronic hepatitis B virus (HBV) compared an older drug adefovir dipivoxil and a newer drug, telbivudine. Researchers found that telbivudine was better at suppressing blood vi read more Sun Oct 2007 Sun Oct 2007

Improving Liver Cancer Diagnosis

Categorie : Liver Disease / Hepatitis
Researchers report in the October 2007 issue of Molecular & Cellular Proteomics that they have identified proteins that could be used to improve the diagnosis of hepatocellular carcinoma, the most common type of liver cancer. Hepatocellular carcinoma causes about one million deaths each year an ...

read more Researchers report in the October 2007 issue of Molecular & Cellular Proteomics that they have identified proteins that could be used to improve the diagnosis of hepatocellular carcinoma, the most common type of liver cancer. Hepatocellular carcinoma causes about one million deaths each year an read more Sun Oct 2007 Sun Oct 2007

October Is Liver Awareness Month: The American Liver Foundation Urges All Americans To Pay Attention To Their Liver Every Day Of The Year

Categorie : Liver Disease / Hepatitis
Urging every American to maintain a healthy liver, the American Liver Foundation (ALF) today observed Liver Awareness Month by releasing 12 tips to combat liver disease, which affects 30 million Americans. Liver disease, a serious and largely unrecognized problem in the United States, is the 7 ...

read more Urging every American to maintain a healthy liver, the American Liver Foundation (ALF) today observed Liver Awareness Month by releasing 12 tips to combat liver disease, which affects 30 million Americans. Liver disease, a serious and largely unrecognized problem in the United States, is the 7 read more Sun Oct 2007 Sun Oct 2007

Pharmasset Commences Dosing In 28-Day Combination Study Of R7128 With Pegasys(R) Plus Copegus(R) For Hepatitis C

Categorie : Liver Disease / Hepatitis
Pharmasset, Inc. (Nasdaq: VRUS) has commenced dosing in a Phase 1 study of R7128 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in up to 75 treatment-naive patients chronically infected with hepatitis C virus (HCV) genotype 1. R7128 is a prodrug of PSI-6130, a ...

read more Pharmasset, Inc. (Nasdaq: VRUS) has commenced dosing in a Phase 1 study of R7128 in combination with Pegasys (pegylated interferon) plus Copegus (ribavirin) in up to 75 treatment-naive patients chronically infected with hepatitis C virus (HCV) genotype 1. R7128 is a prodrug of PSI-6130, a read more Sun Oct 2007 Sun Oct 2007

Liver Transplantation Successful In Over 60's

Categorie : Liver Disease / Hepatitis
Patients who undergo liver transplantation at age 60 or above have 1-year and 5-year survival rates similar to those of younger patients and they experience fewer episodes of rejection. These findings are published in a new study in the October issue of Liver Transplantation, a journal publi ...

read more Patients who undergo liver transplantation at age 60 or above have 1-year and 5-year survival rates similar to those of younger patients and they experience fewer episodes of rejection. These findings are published in a new study in the October issue of Liver Transplantation, a journal publi read more Sun Oct 2007 Sun Oct 2007

Irish Government Launches Program To Provide Life Insurance To People With HIV, Hepatitis C Through Contaminated Blood Products

Categorie : Liver Disease / Hepatitis
The Irish government on Thursday launched a program to provide life insurance, mortgage protection and travel insurance to people who contracted HIV or hepatitis C through contaminated blood products, Ireland's Evening Echo reports (Evening Echo, 9/27). [click link for full article] ...

read more The Irish government on Thursday launched a program to provide life insurance, mortgage protection and travel insurance to people who contracted HIV or hepatitis C through contaminated blood products, Ireland's Evening Echo reports (Evening Echo, 9/27). [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Fighting The Treacherous Hepatitis B

Categorie : Liver Disease / Hepatitis
One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.Those infected with hepatitis B often ...

read more One in four people who are chronically infected with hepatitis B will die from its impact if untreated, but a team of researchers at the Stanford University School of Medicine has identified the most cost-effective way of fighting this treacherous infection.Those infected with hepatitis B often read more Sun Oct 2007 Sun Oct 2007

Bleeding Severity In Portal Hypertension May Be Reduced By Ultra-Low-Dose Aspirin

Categorie : Liver Disease / Hepatitis
In rats with portal hypertension, ultra-low-dose aspirin has shown a normalizing effect of platelet-endothelial cell alterations and bleeding time. Further, this effect is mediated by Cyclooxygenase 2 inhibition.This study, performed by a team led by Professor C. Doutremepuich, is descri ...

read more In rats with portal hypertension, ultra-low-dose aspirin has shown a normalizing effect of platelet-endothelial cell alterations and bleeding time. Further, this effect is mediated by Cyclooxygenase 2 inhibition.This study, performed by a team led by Professor C. Doutremepuich, is descri read more Sun Oct 2007 Sun Oct 2007

Ultrasound-Guided Liver Biopsy Is The Procedure Of Choice, Over 2 Decades Experience Shows

Categorie : Liver Disease / Hepatitis
Liver biopsy is a widely used tool in the investigation of liver diseases. It is invasive and has a mortality risk ranging between 0.01% and 0.17%. A liver biopsy should therefore only be performed in patients who would potentially benefit from it. Over the last two decades, we have seen a staggerin ...

read more Liver biopsy is a widely used tool in the investigation of liver diseases. It is invasive and has a mortality risk ranging between 0.01% and 0.17%. A liver biopsy should therefore only be performed in patients who would potentially benefit from it. Over the last two decades, we have seen a staggerin read more Sun Oct 2007 Sun Oct 2007

Gilead Submits Marketing Applications In USA & EU For Viread® (Tenofovir Disoproxil Fumarate) For The Treatment Of Chronic Hepatitis B

Categorie : Liver Disease / Hepatitis
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and a Type II variation to the European Medicines Agency (EMEA) for marketing approval of Viread® (tenofovir disoproxil fumarate) ...

read more Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and a Type II variation to the European Medicines Agency (EMEA) for marketing approval of Viread® (tenofovir disoproxil fumarate) read more Sun Oct 2007 Sun Oct 2007

Researching Cure For Liver Cirrhosis

Categorie : Liver Disease / Hepatitis
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. In patients with compensated (early stage) hepatitis C virus-related cirrhosis, antiviral c ...

read more The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. In patients with compensated (early stage) hepatitis C virus-related cirrhosis, antiviral c read more Sun Oct 2007 Sun Oct 2007

Peregrine Pharmaceuticals Doses First Patient In Clinical Trial Of Bavituximab In HCV Patients Co-Infected With HIV

Categorie : Liver Disease / Hepatitis
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted therapies for the treatment of cancer and hepatitis C virus infection (HCV), announced that the first patient has been dosed in a clinical trial designed to evaluate the safety and ph ...

read more Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing targeted therapies for the treatment of cancer and hepatitis C virus infection (HCV), announced that the first patient has been dosed in a clinical trial designed to evaluate the safety and ph read more Sun Oct 2007 Sun Oct 2007

Hepatitis C Testing Recommended For Anyone With A Tattoo

Categorie : Liver Disease / Hepatitis
The connection between tattoos and hepatitis C virus (HCV) has long been suspected but never completely substantiated. Tattoos and the connection to the disease were clouded by a perceived propensity to other risk factors, such as injection drug use. "Other studies did not exclude patients with ot ...

read more The connection between tattoos and hepatitis C virus (HCV) has long been suspected but never completely substantiated. Tattoos and the connection to the disease were clouded by a perceived propensity to other risk factors, such as injection drug use. read more Sun Oct 2007 Sun Oct 2007

Initial Results Of Phase II Study With HCV Protease Inhibitor Boceprevir In Treatment-Naive Hepatitis C Patients Show A High Rate Of Early Response

Categorie : Liver Disease / Hepatitis
Schering-Plough Corporation (NYSE: SGP) provided an update on the clinical development program for boceprevir, its investigational oral hepatitis C protease inhibitor. [click link for full article] ...

read more Schering-Plough Corporation (NYSE: SGP) provided an update on the clinical development program for boceprevir, its investigational oral hepatitis C protease inhibitor. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

R7128 Receives Fast Track Designation From The FDA For The Treatment Of Chronic Hepatitis C Infection

Categorie : Liver Disease / Hepatitis
Pharmasset, Inc. (Nasdaq: VRUS) has received fast track designation from the U.S. Food and Drug Administration (FDA) for R7128 for the treatment of chronic hepatitis C virus (HCV) infection. R7128 is a prodrug of PSI-6130, an oral cytidine nucleoside analog polymerase inhibitor of HCV that is ...

read more Pharmasset, Inc. (Nasdaq: VRUS) has received fast track designation from the U.S. Food and Drug Administration (FDA) for R7128 for the treatment of chronic hepatitis C virus (HCV) infection. R7128 is a prodrug of PSI-6130, an oral cytidine nucleoside analog polymerase inhibitor of HCV that is read more Sun Oct 2007 Sun Oct 2007

Liver Fibrosis Prediced By MRI

Categorie : Liver Disease / Hepatitis
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY. [click link for full article] ...

read more Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

New Virus Drug Will Have To Shoot At Moving Targets

Categorie : Liver Disease / Hepatitis
The reproduction of the deadly hepatitis B virus is dependent on the mobility of one of the virus's RNAs. This is shown by Katja Petzold and Jurgen Schleucher, Umea University, Sweden, in an article in the latest issue of the journal Nucleic Acids Research.More than 300 million people all over the w ...

read more The reproduction of the deadly hepatitis B virus is dependent on the mobility of one of the virus's RNAs. This is shown by Katja Petzold and Jurgen Schleucher, Umea University, Sweden, in an article in the latest issue of the journal Nucleic Acids Research.More than 300 million people all over the w read more Sun Oct 2007 Sun Oct 2007

Bronchiectasis

Categorie : Liver Disease / Hepatitis
16 year old female house lady came in OPD with the presenting complaints of: • Fever off and on low grade for one year • Productive Cough with copious   sputum for one year. • Shortness of breath gradually increase over the period of one year. • Rec ...

read more 16 year old female house lady came in OPD with the presenting complaints of: • Fever off and on low grade for one year • Productive Cough with copious   sputum for one year. • Shortness of breath gradually increase over the period of one year. • Rec read more Wed Oct 2007 Wed Oct 2007

<<< previous | 1 | 2 | 3 | 4 | 5 next >>>



     


Custom Search